HRTX
Heron Therapeutics, Inc. /De/Company with tickers: HRTX
CIK
818033
CUSIP
427746102
Shares Outstanding
189,279,369
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | $24,073,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Operating Expenses | — | ||||
| Research & Development | $2,385,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-4,765,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-8,111,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-0.04 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-0.04 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |